Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Share-based Compensation (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Share-based Compensation for 15 consecutive years, with $7.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 0.68% year-over-year to $7.2 million, compared with a TTM value of $28.7 million through Dec 2025, down 11.61%, and an annual FY2025 reading of $28.7 million, down 11.61% over the prior year.
  • Share-based Compensation was $7.2 million for Q4 2025 at Orthofix Medical, roughly flat from $7.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $13.2 million in Q2 2023 and bottomed at $3.2 million in Q4 2023.
  • Average Share-based Compensation over 5 years is $6.5 million, with a median of $6.4 million recorded in 2023.
  • Peak annual rise in Share-based Compensation hit 200.55% in 2023, while the deepest fall reached 35.66% in 2023.
  • Year by year, Share-based Compensation stood at $4.0 million in 2021, then rose by 24.23% to $4.9 million in 2022, then crashed by 35.66% to $3.2 million in 2023, then soared by 126.24% to $7.2 million in 2024, then grew by 0.68% to $7.2 million in 2025.
  • Business Quant data shows Share-based Compensation for OFIX at $7.2 million in Q4 2025, $7.2 million in Q3 2025, and $7.8 million in Q2 2025.